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Abstract
Background: The diaphragm is the major respiratory muscle affected by Duchenne muscular dystrophy (DMD) and
is responsible for causing 80% of deaths. The use of mechanical forces that act on the body or intermittent
pressure on the airways improves the quality of life of patients but does not prevent the progression of respiratory
failure. Thus, diseases that require tissue repair, such as DMD, represent a group of pathologies that have great
potential for cell therapy. The application of stem cells directly into the diaphragm instead of systemic application
can reduce cell migration to other affected areas and increase the chances of muscle reorganisation. The mdx
mouse is a suitable animal model for this research because its diaphragmatic phenotype is similar to human DMD.
Therefore, the aim of this study was to assess the potential cell implantation in the diaphragm muscle after the
xenotransplantation of stem cells.
Methods: A total of 9 mice, including 3 control BALB/Cmice, 3 5-month-old mdx mice without stem cell injections
and 3 mdx mice injected with stem cells, were used. The animals injected with stem cells underwent laparoscopy
so that stem cells from GFP-labelled rabbit olfactory epithelium could be locally injected into the diaphragm
muscle. After 8 days, all animals were euthanised, and the diaphragm muscle was dissected and subjected to
histological and immunohistochemical analyses.
Results: Both the fresh diaphragm tissue and immunohistochemical analyses showed immunopositive GFP
labelling of some of the cells and immunonegativity of myoblast bundles. In the histological analysis, we observed
a reduction in the inflammatory infiltrate as well as the presence of a few peripheral nuclei and myoblast bundles.
Conclusion: We were able to implant stem cells into the diaphragm via local injection, which promoted moderate
muscle reorganisation. The presence of myoblast bundles cannot be attributed to stem cell incorporation because
there was no immunopositive labelling in this structure. It is believed that the formation of the bundles may have
been stimulated by cellular signalling mechanisms that have not yet been elucidated.
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Background
Duchenne muscular dystrophy (DMD) has been
described as one of the most devastating, rapidly pro-
gressive and severe forms of hereditary myopathies, with
an incidence of 1 in 3,500 males born [1,2]. DMD is an
X-linked recessive disease caused by a mutation in the
gene encoding a 427-kDa protein located on the short
arm of chromosome X at locus Xp21 [3].
Dystrophin represents only 0.002% of the striated
muscle cell mass and is located at the intracellular
surface of the sarcolemma in combination with several
integral membrane glycoproteins, forming the dystrophin-
associated glycoprotein complex (DGC). The DGC is re-
sponsible for the membrane permeability of muscle cells
that promotes the binding of F-actin, a thin myofilament
protein, to dystroglycan, forming the DGC of cardiac
and skeletal striated muscle cells and smooth muscle cells
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[4]. Although the function of the DGC has not
been elucidated in the literature, it may have a role in
cytoskeleton structural integrity and cell survival
signalling [5].
The first symptoms of DMD are usually reported at 2
years of age, but parents only recognise them at approxi-
mately age 5, when the child begins to have difficulties
going up or down stairs and falls [6]. At approximately
20 to 30 years of age, depending on the ventilation
resources used, the patients die as a result of respiratory
muscle impairment, which is the cause of death in 80%
of DMD patients, due to respiratory failure in addition
to an infection or heart failure. Structural deformities
are characteristic of DMD patients, resulting from their
confinement to a wheelchair. The most serious struc-
tural deformity is scoliosis, the main culprit underlying
the drastic reduction in lung function. Due weakening of
respiratory muscle, these patients are unable to generate
respiratory pressure (maximal inspiratory pressure and
maximal expiratory pressure), and the peak expiratory
flow is reduced. Thus, all of these factors lead to
the premature death of DMD patients [3,7,8]. The main
failure of muscles involved in breathing occurs in the
diaphragm. The reduction in lung compliance and
chest wall mobility leads to an increased mechanical
load sustained with each breath. The onset of hypercap-
nia, pulmonary hypoventilation, hypoxaemia (following
hypercapnia) and, consequently, the clearance of secre-
tions results from weakened musculature. The uses of
mechanical forces acting on the body or intermittent
pressures acting on the airways have helped to improve
the performance of inspiratory and expiratory mus-
cles. Among them, negative pressure body ventilators
(NPBVs) and bilevel positive airway pressure (BiPAP)
improve the quality of life of patients but do not prevent
the progression of respiratory failure [6].
Similarly to human DMD, in mdx mice (X
chromosome-linked muscular dystrophy in the mouse)
muscle inflammation begins at 3 weeks of age, peaking
between 8 and 12 weeks. After this period, inflammation
disappears spontaneously from the muscles. However,
the mdx diaphragm muscle shows moderate endomysial
fibrosis that is aggravated by intense oxidative stress at 3
months of age and worsens at 6 months of age without
the clearance of inflammation [9]. This disease progres-
sion is similar to human DMD [10,11].
The life span of the mdx mouse is reduced, and re-
spiratory and/or cardiac insufficiency is the main cause
of death [12,13]. Recent studies performed using whole-
body plethysmography have shown that the respiratory
rate, tidal volume and minute volume are significantly
reduced in the mdx animals from 2 to 6 months of age
and may worsen at 7 months of age [13,14]. In contrast,
some less recent data report that there is only a small
difference in the tidal volume (Vt) in response to hyper-
capnia in mdx mice at 7 months and little ventilation in
mdx mice at 5 months of age [13,15].
Diseases that require tissue repair, including DMD,
represent a group of pathologies that have great po-
tential for cell therapy. Currently, the use of stem
cells has expanded into new areas of biotechnology
and has been beneficial to the field of regenerative
medicine [16].
Mesenchymal stem cells (MSCs) are characterised as
adherent fibroblastoid cells. They have the capacity to
differentiate into connective tissue cells, including adipo-
cytes, osteocytes and myocytes, and there is evidence
that MSCs can selectively differentiate in injured tissues
[17]. Among the stem cells source in adult organisms,
the bulb olfactory has been studied as a potential source
of multipotent stem cells in many species. For example,
in rats, the fibroblast-like cells isolated from the olfac-
tory bulb showed to express mesenchymal cells markers
such as CD29 and CD90 and are also able to differenti-
ate along osteoblastic, adipogenic and chondrogenic
lineages [18].
Neural stem cells can be characterized on a critical
functional basis in terms of their undifferentiated
features, capacity for self-renewal, pluripotentiality, and
ability to regenerate damaged tissue and these character-
istics have been found in culture of embryonic and adult
murine brain [19]. One of the most promising sources of
neural stem cells with unique characteristics are the ol-
factory epithelial stem cells because they are close to the
higher central nervous system (CNS) and may be easily
obtained in humans through a biopsy of the external
nostrils [20].
Therefore, the aimed to assess the potential cell im-
plantation and muscle morphology following xenotrans-
plantation performed by the local injection of stem cells
into the dystrophic diaphragm.
Materials and methods
This research was certified by the Ethical Principles in
Animal Research adopted by “Ethic Committee in the
use of animals” of the School of Veterinary Medicine
and Animal Science of University of São Paulo, protocol
number 2045/2010.
Animals
A total of 6 mdx mice from the Vivarium at FMABC
and 3 BALB/C57 mice from the Pathology Vivarium at
FMVZ/USP were used. All animals used in the experi-
ment were 5-month-old males. The animals were
divided into the following 3 groups:
Group A 3 BALB/C57 control mice without
mesenchymal stem cell implantation;
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Group B 3 mdx controls without mesenchymal stem
cell implantation;
Group C 3 mdx mice treated with local injections of
mesenchymal stem cells.
Isolation, culture and genetic modification of adult
stem cells
Mesenchymal stem cells have been previously isolated
from rabbit olfactory epithelium (REF), cultured in
DMEM/F12 medium supplemented with 10% foetal bo-
vine serum, 1% nonessential amino acids, glutamine and
antibiotics and characterised (Ambrosio et al., unpub-
lished data). The cells were exposed to lentiviral trans-
duction for enhanced green fluorescent protein (eGFP)
expression [21,22]. Briefly, the viral particles were pro-
duced in 293FT cells via lipofection of packaging plas-
mids and the FUGW plasmid. After 72 h of incubation,
the supernatant was filtered at 0.45 μm and used for the
infection of 2 x 105 cells for approximately 16 h. After
this period, the culture medium was replaced, and the
cells were cultured in vitro for a minimum of 3 days be-
fore use in vivo.
Laparoscopy
The laparoscopic procedure was performed at the Veter-
inary Hospital of FMVZ-USP. Anaesthesia was initiated
intraperitoneally with a combination of 50 mg/kg keta-
mine hydrochloride (Ketamin-SW, Cristália) and 2 mg/kg
xylazine hydrochloride (CalmiunW, Agener União), and
the animals were kept under spontaneous breathing.
The animals were positioned in dorsal decubitus with
a 20-degree elevation of the forelimbs. Subsequently, an
incision was made at the midline sagittal plane under
the 0.5-cm linea alba in the lower third of the abdomen
to introduce the 2.7-mm laparoscope. The laparoscope
was fixed with an “X” suture, and the pneumoperito-
neum was established using a 25X7G needle parallel to
the laparoscope with carbon dioxide (CO2). The surgery
proceeded, and upon visualisation of the diaphragm
muscle, a 24G catheter needle connected to an insulin
syringe containing the MSCs was introduced into the
10th intercostal space.
Xenotransplantation
Mesenchymal stem cells from rabbit olfactory epithelium
were xenotransplanted at a concentration of 2x105 cells
suspended in sterile saline solution. No immunosuppres-
sive drugs were used.
Prophylactic protocol
The post-surgical protocol consisted of 2.5 mg/kg flu-
nixin meglumine for 3 days and 2 mg/kg of meperidine
hydrochloride 3 times a day for 5 days for analgesia. For
prophylactic antibiotic therapy, 10 mg/kg enrofloxacin
was administered intramuscularly twice per day. After
8 days, the animals were euthanised with an overdose of
anaesthesia, and the diaphragmatic muscles, together
with the intercostal muscles, were collected in sterile
plates containing PBS solution to wash the material.
Histological analysis
In all groups, the diaphragm muscle fragments were col-
lected and fixed in 4% paraformaldehyde for 24 hours.
They were then dehydrated in an ascending ethanol
series (70% to 100%), made diaphanous in xylene and
embedded in ParaplastW (Leica/Germany), from which
3x4 cm rectangular blocks were prepared. Then, 5-μm
serial sections were generated using an automatic micro-
tome (Leica RM 2065) to prepare the slides, which
were subsequently deparaffinised in an oven at 60°C for
2 hours.
Hematoxylin-eosin staining was used for the structural
and histopathological analysis of the dystrophic muscle
characteristics [23]. The slides were imaged using an
Olympus BX 60 Microscope coupled to an Axio CAM
HRc camera with ZeissW KS 400 software.
Immunohistochemical analysis
The identification of GFP (green fluorescent protein) in
the diaphragm of the animals euthanised 8 days after the
injection of rabbit olfactory epithelial stem cells was per-
formed using anti-GFP antibodies (Living Colours GFP
Monoclonal Antibody, Clontech, cat. # 632375, Foster
City,Califórnia 94404, USA).
The 5-μm sections were deparaffinised in xylene and
rehydrated in a series of solutions with decreasing etha-
nol concentrations. The sections were heated in citrate
buffer (0.384 g citric acid monohydrate and 2.352 g so-
dium citrate tribasic dihydrate in 1 L of distilled water,
pH 6.0) for 15 minutes in a microwave oven to perform
antigen retrieval. The endogenous tissue peroxidase ac-
tivity was blocked by incubation in a 3% solution of
hydrogen peroxide in 1 M Tris–HCl buffer, pH 7.5 (TBS,
60.57 g Tris in 500 mL ultrapure water), for 30 minutes.
The sections were incubated with 10% goat serum in
TBS for 30 minutes to block non-specific binding. The
primary antibody was diluted to 0.2 mg/mL in TBS buf-
fer containing 1% goat serum and incubated overnight at
4°C in a moist chamber. In parallel, slices were incubated
at the same concentration of irrelevant antibody as an
isotype control (IgG, anti-mouse IgG).
After incubation with the primary antibody, all sections
were washed with TBS containing 1% goat serum. The
reaction was visualised using the multipurpose Dako
Advance HRP Link kit (cat. # K4069, Dako, USA) accord-
ing to the manufacturer’s instructions. The reaction was
visualised by precipitation of 3,30-diaminobenzidine (DAB
Peroxidase Substrate Kit, 3,30-diaminobenzidine, cat. #
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SK-4100). Finally, the sections were counter-stained
with hematoxylin, dehydrated and mounted on slides for
light microscopy analysis.
Results
Structural analysis of the diaphragm muscle
In the structural analysis of the diaphragm in the control
animals, group A (Figure 1, A), the presence of basal nu-
clei and epimysium was observed. We found that the
diameter of the muscle fibres was preserved in this
group of animals, and there was no inflammatory infil-
trate, according to the normal muscle morphology [2].
In the mdx group that not received stem cell implants,
i.e., group B (Figure 1, B), the epimysium is present and
a robust perimysial inflammatory infiltrate was observed.
Moreover, the muscle cells displayed central nuclei. In
these animals, we observed the presence of fibres with
various diameters.
Some basal nuclei can be observed in mdx stem cell
treated group (Figure 1, C).The presence of a myoblast
bundle is noted only at stem cell treated group and ex-
hibit long and tubular appearance can be observed in
low (Figure 1, C) and high magnification (Figure 1, D).
Cell implantation analysis
In the fresh tissue analysis of the diaphragm using an
inverted fluorescence microscope, it was possible to
identify clusters of GFP-positive stem cells located
throughout the diaphragm. In the intercostal muscles,
there was a linear structure adjacent to the path of the
needle showing the injection of stem cells, which is
represented in the image by a fluorescent structure
(Figure 2).
In the immunohistochemical reaction with the anti-
GFP antibody, no labelling of the strings of myoblasts or
muscle fibres was observed. Immunopositive labelling
was observed in some cells with dense nuclei present in
the perimysial fibrosis, indicating that the injection
enabled the implantation of stem cells (Figure 3). These
findings confirm the described morphological results
using fresh tissue immunofluorescence.
Discussion
The mdx mouse is an animal model that is amenable to
preclinical trials regarding changes in the diaphragm
muscle. This muscle exhibits morphology, biochemistry
and functions similar to human DMD and may contrib-
ute to new studies of diseases involving the diaphragm.
Currently, regenerative medicine has been applied to
several cases, including myocardial infarction [24], pul-
monary diseases [25], tendinitis [26] and muscle dys-
function [27]. By applying regenerative medicine to the
aforementioned regenerative diseases, the current study
contributes to the use of a safe cell therapy technique.
Figure 1 Photomicrograph of mdx diaphragm muscle before and after stem cells transplantation. In (A) normal BALB/C57 mouse,
showing epimysium (1) and basal nuclei (arrow) in the muscle fibers; (B) Control mdx mouse, showing epimysium (1), perimysial fibrosis (2) and
the central nucleus (arrow).In (C) mdx stem cell treated group, (arrow) indicates basal nuclei and myoblast bundle in the circle. (D) high
magnification of myoblast bundle in the circle.
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Figure 2 Analysis of the diaphragm and intercostal muscle from mdx with stem cell Implant by whole- mount epifluorescence
microscopy. GFP-positive staining can be observed in the diaphragm (A, B and C); (D, E and F) are niches of GFP-labelled stem cells. The
fluorescent intercostal muscles are noted in (G, H and I), tracing a linear path.
Figure 3 GFP detection by immunohistochemistry in longitudinal sections of the diaphragm muscle. (A) An mdx diaphragm transplanted
with stem cells; within the circle, there is an immunonegative string of myoblasts; (B and D) mdx diaphragm transplanted with stem cells,
GFP-immunopositive labelling (→) and (C) the rectus abdominis muscle of an mdx mouse without a stem cell implant as an immunonegative control.
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The mdx mouse has been used as an experimental
model in procedures involving the use of stem cells
(Gussoni et al., 1999 [28]; McKinney-Freeman et al.,
2002 [29]; Corbel et al. [30]; Fukada et al., 2001[31];
Hagiwara et al., 2006 [32]), showing that this model has
been useful for DMD studies.
To best of our knowledge this is the first report on
stem cells local level transplantation in the diaphragm of
mdx mouse. This strategy reduces the migration of stem
cells to other affected areas and to increase the chances
of muscle reorganisation.
The use of cell therapy in the diaphragm muscle was
previously describe by Zhang et al., 2006 [33]. They
examined the effects of xenotransplantation of bone
marrow-derived stem cells isolated from normal rats
into the diaphragm muscles of mdx mice by injection
into the caudal vein in 18 8-week-old mdx females.
These animals were euthanised at 4, 8 and 12 weeks
after the transplantation of stem cells. The authors
found that the proportion of centrally nucleated muscle
fibres was slightly altered compared to the group that
received no stem cell injection, and there was a reduc-
tion in the inflammatory infiltrate.
Regarding the methodology used to access the dia-
phragm, the current study has proposed an alternative
that is easy to perform and safe. In contrast to the study
by Zhang et al., 2006 [33], we used male animals with local
laparoscopic application of stem cells in a specific region
of the diaphragm (costal plane). This method was proven
effective given the histological and immunohistochemical
findings described. These results lead us to believe that
both the systemic and local use of cells may provide the
same efficacy regarding diaphragm muscle reorganisation.
Another issue that should be discussed is the type of
cells used for such therapy. Several authors [28,29,31,32],
used in mdx mouse, bone marrow cells for DMD treat.
Zhang et al., 2006 [33] contributed the use of fetal liver
cells and observed the same results as those obtained
when using bone marrow.
Few studies have reported the use of rabbit olfactory
epithelial stem cells. Marshall et al., 2006 [34] suggested
that olfactory epithelial stem cells show a putative po-
tential for axonal regeneration and for application in de-
myelinating diseases. During a 3-year clinical trial in
patients with chronic spinal cord injury, Mackay-Sim
et al., 2008 [35] used autologous transplantation of olfac-
tory epithelial cells in humans and found no clinical
changes or tumour formation after transplantation.
Currently, several researchers have been used cell therapy
with cells from olfactory epithelium to in order to recovery
of spinal cord injuries (Raisman, 2007; Ramer, et al., 2004;
Li et al., 2004; Ramón-Cueto et al., 1998). In none of these
authors are cited the use of immunosuppressive pre or post
treatment, as well as immune response is not reported
rejection. Furthermore, there are reports indicating that the
use of immunosuppressant agents can improve the muscu-
lar function by itself (ref) that would affect the observation
of the effects of stem cells transplant in our model.
In the present study, we used rabbit olfactory epithelial
cells, which were shown to be potentially effective in
reorganising diaphragm muscles, given that myoblast
bundle formation was clear. However, we believe that
this finding resulted from cellular signalling events that
remain unknown to this date; thus, we cannot attribute
this event to the cell type used.
Conclusion
Although the mdx mouse diaphragm muscle is a mem-
branous structure and, therefore, presents difficulties in
direct intervention, it was shown that stem cell implant-
ation via local application to this muscle generated mod-
erate muscle reorganisation. The diaphragm muscle
exhibited decreased inflammatory infiltrate 8 days after
xenotransplantation. In addition, basal nuclei and the
myoblast bundle were observed, confirming stem cell
implantation in the muscle. We believe that this experi-
ment opens a new avenue for future applications and
cell therapy in the dystrophic dog model, once it can
helps ameliorate the respiratory symptoms associated to
muscle dystrophy disease.
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